Healthy Living
FDA Approves First mRNA Flu Vaccine for Adults 50+
Moderna's new mFlusiva flu shot, the first mRNA vaccine approved for influenza, offers adults aged 50 and older up to 27% more protection against the flu than existing vaccines.
Chloe Bennett·August 7, 2026
